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Abstract
Objectives: The improved management of Fontan patients has resulted in good
outcome. As such, these patients may necessitate care for non-cardiac surgery.
We sought to determine the long-term outcome of our Fontan series palliated
with the most recent surgical techniques. Our second objective was to report
the incidence and the perioperative course after non-cardiac procedures. We
reviewed the records of all patients with either a lateral tunnel or an extracardiac
conduit Fontan between 1996 and 2008. Follow-up was recorded until June,
2013, including records regarding non-cardiac interventions. Results: Overall, 58
patients were included. Of them, one patient underwent a takedown of his Fontan,
and five patients died in the immediate postoperative course. The cumulative
survival of the remaining 52 patients was 81%. There was no significant difference
in survival between right and left ventricle morphologies (p=0.56), nor between
both types of Fontan (p=0.9). Chronic arrhythmias (25...
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Abstract Objectives: The improved management of Fontan patients has resulted in good outcome. As such, these
patients may necessitate care for non-cardiac surgery. We sought to determine the long-term outcome of our
Fontan series palliated with the most recent surgical techniques. Our second objective was to report the incidence
and the perioperative course after non-cardiac procedures. We reviewed the records of all patients with either a
lateral tunnel or an extracardiac conduit Fontan between 1996 and 2008. Follow-up was recorded until June,
2013, including records regarding non-cardiac interventions. Results: Overall, 58 patients were included. Of
them, one patient underwent a takedown of his Fontan, and ﬁve patients died in the immediate postoperative
course. The cumulative survival of the remaining 52 patients was 81%. There was no signiﬁcant difference in
survival between right and left ventricle morphologies (p= 0.56), nor between both types of Fontan (p= 0.9).
Chronic arrhythmias (25%), fatigue/dyspnoea (40%), thrombotic complications (19%), and embolic events
(10%) were among the most recurrent comorbidities. In total, 45 non-cardiac interventions were performed on
26 patients, with three bleeding complications and one death. Conclusions: This study shows excellent long-term
survival after both lateral tunnel and extracardiac conduit Fontan. The incidence of cardiovascular morbidity
remains high, however. We also report a high number of non-cardiac interventions. Thorough understanding of
the Fontan physiology is mandatory when non-cardiac anaesthesiologists are in charge of these patients.
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SINCE THE INTRODUCTION OF THE FONTAN PROCE-dure in 1971,1 there have been improvements inthe surgical techniques as well as in the medical
management of patients with single ventricle
physiology. The improved management of patients
undergoing a Fontan procedure has resulted in
decreased early and late mortality, demonstrated by
numerous centres.2–4 As such, these patients like any
individual may necessitate elective or urgent non-
cardiac surgery in a centre not familiar with their
anatomy and physiology.
The aim of this study was, ﬁrst, to determine the
long-term outcome of our Fontan series palliated with
the most recent surgical techniques, with speciﬁc focus
on cardiovascular morbidity andmortality. The second
objective of this study was to report the incidence
and the perioperative course after anaesthesia for non-
cardiac procedures in this cohort of patients.
Materials and methods
We reviewed the records of all patients who had
undergone a Fontan procedure between 1996 and
2008. The surgical technique was either a lateral
tunnel or an extracardiac conduit. Their follow-up was
recorded until June, 2013. Follow-up was analysed as
completely as possible, with records from our internal
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database and reports sent from the primary care physi-
cians and/or referring cardiologists. With regard to data
on non-cardiac interventions, all procedures necessitating
general anaesthesia or sedation were included. Data on
non-cardiac interventions performed in other hospitals
were also included if available. Exclusion criteria were
patients who underwent non-cardiac interventions
during their admission for the Fontan procedure.
Statistical analysis
All data are expressed as mean± standard deviation,
median (percentile 25–percentile 75) or numbers and
percentages as appropriate. A Mann–Whitney test
was used to compare quantitative variables between
different independent groups. A χ2 or Fisher’s
exact test was used for comparison of dichotomic
variables between different independent groups. The
probability of survival is estimated using the
Kaplan–Meier method. The Kaplan–Meier curve was
computed from the date of Fontan surgery to the date
of death or last follow-up (censored cases). A log-rank
test was used to compare the survival between the
different groups of patients. A p< 0.05 is considered
signiﬁcant. All the p-values are two-tailed. Statistical
analysis was performed using IBM SPSS Statistics 21.
Results
Overall, 58 patients were eligible and included for
analysis. Their characteristics are shown in Table 1.
Tricuspid atresia was by far the most common diag-
nosis. Left ventricle morphology was present in 72% of
the patients. Right ventricle morphology was found in
26% of the patients. Of the patients, one showed
biventricular anatomy, and three underwent conversion
of an earlier atriopulmonary Fontan to either a lateral
tunnel or an extracardiac conduit Fontan.
Fontan procedure
Table 2 illustrates the perioperative and postoperative
data. Immediate post-Fontan complications occurred in
91% of patients. Prolonged pleural effusion, low cardiac
output, and arrhythmias were among themost common
complications. One patient underwent a takedown of
his lateral tunnel because of severe vena cava syndrome
and low cardiac output. This patient has been elimi-
nated from further follow-up analyses. Patients operated
using a lateral tunnel had signiﬁcantly a longer duration
of aortic cross-clamp time (p<0.001), a longer ICU
stay (p<0.001), and a longer length of stay in hospital
(p= 0.03) compared with the extracardiac conduit
Fontan group.
It is noteworthy that in our series only 17 patients
(29%) underwent a Fontan procedure without aortic
cross-clamp. Nowadays all our Fontan operations are
performed without aortic cross-clamp.
There were ﬁve patients who died in the early
postoperative course; of them, four patients had
undergone a lateral tunnel, and one an extracardiac
conduit procedure. There was no statistically sig-
niﬁcant difference in the early mortality with regard
to the type of surgery (p= 0.39) or the morphology of
the single ventricle (p= 0.60). Causes of death were
major arrhythmias and severe low cardiac output.
Long-term follow-up analysis
Long-term follow-up was analysed for the remaining
52 patients. Themaximum follow-up was 17 years with
a cumulative survival of 81%, as shown in Figure 1.
Mean survival time was 15 years with a 95% conﬁdence
interval of 13.4–16.4 years. There was no signiﬁcant
difference in long-term survival when morphologies of
single ventricle were compared (74% for right ventricle
versus 84% for left ventricle; log-rank p=0.56) (Fig 2).
The type of Fontan surgery did not inﬂuence the long-
term survival as shown in Figure 3 (71% for extra-
cardiac conduit versus 82% for lateral tunnel; log-rank
p=0.9).
There were three late deaths: one patient died of a
hepatocarcinoma, one died after an attempt to restore a
biventricular physiology, and one died from bleeding
and low cardiac output after a gynaecologic intervention.
The atrioventricular valve competence was evaluated in
all the patients. Table 3 illustrates these follow-up data.
No patient was on a transplant list or had been trans-
planted at the end of the study. Mean oxygen saturation
of the overall cohort was 93±3%.
Chronic arrhythmias – including three permanent
pacemaker implantation – fatigue/dyspnoea, and
thromboembolic complications were among the most
recurrent cardiovascular morbidity factors. Thrombo-
embolic complications were divided into early and late
presentation to distinguish the pathophysiological
mechanisms. Indeed, strategies to prevent early events
differ from those used to prevent later complications.
Late thrombotic complications occurred in four
patients, despite chronic aspirin intake. The diag-
nosis of thrombosis was either clinical or made by
routine echographic imaging. All embolic complica-
tions occurred in patients in whom a fenestration
had been created at the time of surgery. Only new
thromboembolic events after the Fontan procedure
were taken into consideration. Thromboembolic
complications before Fontan palliation were not con-
sidered for this analysis.
Non-cardiac procedures
Of the 52 patients considered for the long-term
follow-up, 48 (92%) required general anaesthesia for
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cardiac catheterisation. Device closure of the fenestra-
tion was performed in 32% of the patients and was the
most frequent indication for cardiac catheterisation.
Of the patients, 26 (50%) patients necessitated
a non-cardiac intervention. In total, 45 interventions
were performed. The perioperative data related to these
non-cardiac interventions are shown in Table 4. Most of
these interventions were in the low-risk stratiﬁcation
category. No high-risk surgery has been recorded.
Outpatient surgery was performed on 10 patients
without any rehospitalisation. In total, four patients
were transfused. There were three bleeding complica-
tions, of whom one necessitated reintervention. There
were two patients who needed inotropic support, and
one patient developed lactic acidosis because of
hypovolemia. Postoperative death occurred in one
patient. This 33-year-old woman with a good func-
tioning Fontan underwent an uneventful gynaecologic
procedure. On the ﬁrst postoperative day, she presented
major bleeding requiring an emergency reoperation.
Postoperative severe ventricular tachyarrhythmias and
subsequently severe ventricular dysfunction resulted in
death. There were otherwise no other complications.
Discussion
This single-centre, retrospective study conﬁrms the
excellent long-term survival of patients who underwent
a Fontan procedure using a lateral tunnel or an extra-
cardiac conduit technique. The cumulative survival rate
Table 1. Characteristics of patients (n= 58).
Demographics
Male/Female 38 (66%)/20 (34%)
Age at Fontan surgery (years; median (P25–P75)) 4 (3–5)
Weight (kg; median (P25–P75)) 14 (13–17)
Pre-Fontan heart catheterisation 47 (81%)
Cardiac diagnosis
Tricuspid atresia 28 (48%)
Pulmonary atresia with intact ventricular septum 4 (7%)
Double inlet left ventricle 9 (16%)
Complete atrioventricular canal 7 (12%)
Double inlet right ventricle 2 (3%)
Hypoplastic left heart syndrome 3 (5%)
Mitral atresia 2 (3%)
Complex 3 (5%)
Associated morphologic abnormalities
Dextrocardia 7 (12%)
Pulmonary stenosis/atresia 26 (45%)
Transposition of great arteries 21 (36%)
Coarctation of the aorta 6 (10%)
Subvalvular aortic stenosis 3 (5%)
Left superior vena cava 5 (9%)
Heterotaxy syndrome 3 (5%)
Other 9 (16%)
Single ventricle morphology
Right 15 (26%)
Left 42 (72%)
Biventricular 1 (2%)
Staged procedure pre-Fontan
None 3 (5%)
Single-stage procedure 8 (14%)
Two- or more-stage procedure 47 (81%)
Previous Fontan 3 (5%)
Type procedures pre-Fontan
Pulmonary artery banding 15 (26%)
Modiﬁed Blalock–Taussig shunt 27 (47%)
Central shunt 2 (3%)
Coarctation repair 6 (10%)
Norwood procedure 3 (5%)
Damus–Kaye–Stansel connection 7 (12%)
Bidirectional cavopulmonary shunt 46 (79%)
Glenn 6 (10%)
Redo Fontan 3 (5%)
Other 4 (7%)
P25= percentile 25; P75= percentile 75
Data are expressed in numbers (%)
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after 17 years of follow-up was 81% in our study. There
was no signiﬁcant difference in long-term survival rate
between patients who underwent a lateral tunnel versus
an extracardiac conduit procedure. No signiﬁcant
difference was observed between both techniques with
regard to the incidence of fatigue/dyspnoea, chronic
arrhythmias, and thromboemebolic complications at
long-term follow-up, despite the perioperative sig-
niﬁcant differences noted between the two groups at
the time of the index procedure: patients in the lateral
group had longer aortic cross-clamp time, longer ICU,
and hospital stay when compared with the extracardiac
Table 2. Fontan procedure: perioperative and postoperative data (n= 58).
Overall cohort LT/ECC (34/24) LV/RV (42/15) **
Fenestration 56 (97%) 34/22 41/14
CPB time (minutes; median (P25–P75)) 105 (83–128) 110 (93–128)/98 (65–120) 105 (77–127)/103 (93–131)
ACC time (minutes; median (P25–P75)) 47 (0–66) 55 (48–72)/0 (0–22)* 47 (0–65)/54 (0–67)
Immediate postop complications 53 (91%)
Extra-corporeal life support 2 (3%)
Prolonged pleural effusion 38 (66%) 22 (65%)/16 (67%) 28 (67%)/10 (67%)
Low cardiac output 23 (40%) 16 (47%)/7 (29%) 13 (31%)/9 (60%)
Arrhythmias 19 (33%) 11 (32%)/8 (33%) 16 (38%)/3 (20%)
Fontan takedown 1 (2%)
Death 5 (9%) 4 (12%)/1 (4%) 3 (7%)/2 (13%)
ICU stay (days; median (P25–P75)) 5 (3–7) 7 (5–11)/4 (2–6)* 5 (3–7)/7 (5–13)*
LOS hospital (days; median (P25–P75)) 13 (11–20) 14 (11–26)/12 (10–17)* 12 (10–20)/17 (12–25)
Medication at discharge (n= 52)
Aspirin 46 (80%)
Anticoagulation therapy 10 (17%)
Diuretics 36 (62%)
ACE-inhibitors 47 (81%)
ACC= aortic cross-clamp; CPB= cardiopulmonary bypass; ECC= extracardiac conduit; LOS= length of stay; LT= lateral tunnel; LV= left ventricle;
P25= percentile 25; P75= percentile 75; RV= right ventricle
Data are expressed as numbers (%)
*p< 0.05 in-between group
**One patient had a biventricular anatomy
Figure 1.
Kaplan–Meier survival curve for entire group.
Figure 2.
Kaplan–Meier survival curve in function of single ventricle (SV)
morphology. LV= left ventricle; RV= right ventricle.
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conduit group. The better short-term outcome of
our patients in the extracardiac conduit group is in
contrast with a very large database5 where patients in
the lateral atrial tunnel group showed superior early
outcome compared with the extracardiac Fontan group.
One explanation might be the signiﬁcant shorter aortic
cross-clamp time in our patients who underwent an
extracardiac conduit operation, which has not been
analysed in the latter study. Another explanation
might be that our patients in the lateral tunnel group
were sicker before their Fontan surgery. The retro-
spective nature of our study does not allow to conﬁrm
this point. However, our results concur with other
publications where very similar short- and mid-term
outcome has been reported for both techniques.6,7
Finally, this study has focused on the long-term out-
come and in this regard no signiﬁcant difference could
be found between both techniques that is in line with a
large retrospective study describing the early and late
outcome following the Fontan procedure.3
In the past few years, much interest has been given
to the morphology of single ventricle. Although it
was previously presumed that a morphological right
ventricle is not suited to function as a systemic ventri-
cle at long term,8,9 several studies have failed to
demonstrate a signiﬁcant difference in the long-term
outcome after Fontan whether the single ventricle is
morphologically right or left.3,10–13 Our study con-
ﬁrms those data. We did not observe any signiﬁcant
difference in the long-term survival rate of patients
with a morphological right ventricle compared with a
single ventricle of left morphology (p= 0.56). We
also evaluated the atrioventricular valve competence
with regard to the morphology of the single ventricle.
Patients with right ventricular morphology did not
show signiﬁcantly more regurgitant atrioventricular
valve when compared with patients with a single ven-
tricle of left morphology. A study conducted on a large
cohort of children showed that the atrioventricular
valve regurgitation was more prevalent in patients with
a dominant right ventricle.14 Our study population is a
small cohort compared with the population of the
latter trial, which may explain the discrepancies in
the results. Nevertheless, our ﬁndings regarding the
Table 3. Follow-up data (n= 52).
Overall cohort LT/ECC (23/29) LV/RV (39/13)
Chronic arrhythmia 13 (25%) 7 (30%)/6 (21%); p= 0.80 8 (21%)/5 (38%); p= 0.27
Dyspnoea and/or fatigue 21 (40%) 10 (43%)/11 (38%); p= 0.33 13 (33%)/8 (62%); p= 0.07
Thrombotic complications 10 (19%) 7 (30%)/3 (10%); p= 0.48 7 (18%)/3 (23%); p= 0.70
Early manifestation 7
Late manifestation 4
Embolic complications 5 (10%) 3 (13%)/2 (7%); p= 1.0 5 (13%)/0; p= 0.31
Early manifestation 2
Late manifestation 3
Chronic aspirin intake 48 (92%)
AV valve regurgitation
None to mild 51 (98%) 39 (100%)/12 (92%); p= 0.25
Moderate to severe 1 (2%) 0/1 (8%); p= 0.25
GA for cardiac catheterisation 48 (92%)
1GA 42 (81%)
2GA 6 (12%)
3GA 1 (2%)
AV= atrioventricular; ECC= extracardiac conduit; GA= general anaesthesia; LT= lateral tunnel; LV= left ventricle; RV= right ventricle
Data are expressed in numbers (%)
Figure 3.
Kaplan–Meier survival curve in function of the type of Fontan
surgery.
Palumbo et al: Long-term outcome after Fontan palliation 5
atrioventricular valve competence in our patients con-
cur with the good survival rate of our cohort, regardless
of the morphology of the single ventricle.
One of the striking points of this study was the high
incidence of thrombotic and/or embolic complications.
The reported incidence of thromboemebolic events in
Fontan patients varies widely from 3 up to 20%. This is
mainly because of the retrospective type of most trials
including a heterogenous group of patients followed
over variable time periods. Moreover, the diagnostic
methods to detect these complications were not stan-
dardised.15 In our series, 92% of the patients were
chronically on a low-dose aspirin. One patient presented
with thrombosis of his extracardiac conduit. All the
other patients showed peripheral vascular thrombosis.
Those vascular thromboses were indeed promoted by
the multiple cardiac catheterisations performed after the
Fontan procedure. Our results open the debate about
the ideal anticoagulation therapy in these patients.
To date, there is no clear consensus about which
anticoagulation is the best choice for these patients.
In their recent practice guidelines, the American
College of Chest Physicians recommend aspirin or
therapeutic unfractioned heparin followed by vitamin
K antagonists (grade 1C).16 A recent meta-analysis
of antiplatelet versus anticoagulation therapy after
extracardiac conduit Fontan analysed 20 studies over a
follow-up period ranging from 2 to 144 months. The
overall thromboembolism rate was 5.2%. The antic-
oagulation therapy compared with the antiplatelet
therapy did not reduce the incidence of thromboem-
bolic complications.17 The only available prospective,
randomised controlled trial compared warfarin with
acetylsalicylic acid and found a cumulative thrombosis
rate of 23% in the ﬁrst 2 years post-Fontan.18 The risk
of thrombosis, however, was not signiﬁcantly different
between both groups. Considering these data, only
well-conducted randomised trials will be able to shed
some light into this controversial subject. The embolic
manifestations observed in our study are another issue.
There is much debate whether a fenestration should be
routinely performed at the time of surgery. Fenestra-
tion improves the short-term outcome mainly by
decreasing pleural effusions and the length of hospital
stay.19 However, the persistence of a fenestration puts
the patient at higher risk of paradoxical embolus. As a
matter of fact, one of our patients suffered a cerebro-
vascular accident during device closure of his fenestra-
tion. Moreover, long-term studies have not been able
to demonstrate the superiority of fenestrated Fontan
surgery versus unfenestrated Fontan.3,10
In light of the important cardiovascular comor-
bidities observed in the Fontan population, we also
sought to report the incidence and the perioperative
management of Fontan patients who were adminis-
tered anaesthesia for any non-cardiac procedure. Of
our patients, 50% underwent at least one non-cardiac
intervention, and in total 45 interventions were
performed. Although these numbers are rather high,
they may not reﬂect the true incidence of general
anaesthesia in this patient population as other non-
cardiac interventions might have taken place in
other hospitals that are not included in our database.
Despite overall low postoperative complications, one
death occurred in a patient with a well-functioning
Fontan. There are few reports of outcomes of general
anaesthesia for non-cardiac surgery in Fontan patients.
Rabbitts et al20 reported their 22-year period experi-
ence obtained from a database of 1133 Fontan patients
at the Mayo Clinic in Rochester. Surprisingly, they
had only 39 non-cardiac surgeries performed on
31 patients. The ﬁrst reason is that they only included
patients older than 16 years, and second all diagnostic
procedures or procedures without any incision were
excluded. On the contrary, we have also considered
the diagnostic interventions requiring anaesthesia. As
such, we believe that our data represent fairly the type
of non-cardiac interventions this population requires.
Moreover, our series represent Fontan patients of all
ages. This is important considering the growing num-
ber of adult Fontan patients in the general population
and the increasing probability for these patients to be
managed by non-cardiac anaesthesiologists.
Table 4. Perioperative data on non-cardiac interventions.
Number of patients requiring non-cardiac surgery 26 (50%)
Number of interventions 45
One intervention 12 (46%)
Two interventions 10 (38%)
Three interventions 3 (12%)
Four interventions 1 (4%)
Age at non-cardiac surgery (years; median (P25–P75)) 11 (6–18)
Type of surgery
Ear/nose/throat 22 (49%)
Musculoskeletal 9 (20%)
Digestive system 2 (4%)
Urinary system 2 (4%)
Vascular surgery 3 (7%)
Gynaecologic surgery 3 (7%)
Miscellaneous 4 (9%)
Intermediate risk/low-risk surgery 9/36
Emergency surgery 3 (7%)
Outpatient surgery 10 (22%)
Number of patients requiring postoperative ICU stay 5 (19%)
LOS hospital (median (P25–P75)) 1 (0–2)
LRA in addition to GA 3 (7%)
Airway management
Endotracheal tube 33 (73%)
Laryngeal mask airway 6 (13%)
Spontaneous mask breathing 6 (13%)
Invasive blood pressure monitoring 6 (13%)
GA= general anaesthesia; LOS= length of stay; LRA= locoregional
anaesthesia; P25= percentile 25; P75= percentile 75
Data are expressed in numbers and percentages
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Limitations
This retrospective study includes a small cohort of
patients. The lack of signiﬁcant difference between
different groups should therefore be interpreted with
caution. Because of the small number of patients, it
was also not possible to predict determinant factors
of mortality. Thrombotic complications were not
routinely searched. Their incidence could have been
underestimated.
Conclusions
This single-centre, retrospective analysis shows excellent
long-term survival for patients who underwent a lateral
tunnel or extracardiac Fontan operation, regardless of the
morphology of single ventricle and the surgical techni-
que used. Our results also conﬁrm previous reports of
high cardiovascular morbidity, especially chronic
arrhythmias and thromboembolic complications. The
latter raises questions about the ideal type and dose of
anticoagulation therapy for these patients and the
beneﬁts of performing a fenestration at the time of
Fontan procedure.
This study reports a high incidence of general anaes-
thesia for non-cardiac interventions in this patient
population. In the presence of chronic cardiovascular
comorbidities observed, it is of utmost importance that
the physicians in charge of these patients fully under-
stand their anatomy and physiology.
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